http://www.nature.com/ki/podcast/rss/ki.xml The Kidney International Podcast highlights news and articles published in Kidney International, including interviews with the people behind the science and in-depth commentary and analysis from journalists covering the research. en © 2009 Nature Publishing Group Wed, 1 July 2009 14:00:00 GMT Science Technology Education http://www.nature.com/ki/podcast/images/currentshow.jpg http://www.nature.com/ki/podcast/rss/ki.xml 144 144 Kidney International The stories behind the hottest kidney research in Kidney International The Kidney International Podcast highlights news and articles published in Kidney International, including interviews with the people behind the science and in-depth commentary and analysis from journalists covering the research. Kidney International podcast@nature.com © 2009 Nature Publishing Groupkidney,renal,nephrology,dialysis,hypertension,urology,transplantation,diabetes,clinico,pathological,KI,nature,journals,nature,publishing,group,International,Society,of,Nephrology,ISN,/,<meta,name,description,content,Kidney,InternationaScience & Medicine/MedicineScience & Medicine/Natural Sciencespodcast@nature.comnokidney,renal,nephrology,dialysis,hypertension,urology,transplantation,diabetes,clinico,pathological,KI,nature,journals,nature,publishing,group,International,Society,of,Nephrology,ISN,/,<meta,name,description,content,Kidney,InternationaKidney International - PodcastsThe Kidney Podcast is an audio file you can play on any computer - you don't need an iPod. See our help and FAQ section for instructions on listening and subscribing to the Kidney Podcast and for more information about podcasts. http://feeds.nature.com/~r/ki/podcast/current/~3/djlTmt1b32I/ki_01072009.mp3 The latest podcast from Kidney International focuses on MYH9 and its role in Focal Segmental Glomerulosclerosis and related disorders. MYH9 is strongly associated with the disease historically labeled "hypertension-associated" ESRD. Recent genetic studies suggest that the spectrum of FSGS- and global glomerulosclerosis-related kidney diseases are likely present in African Americans reportedly with hypertensive ESRD". The podcast features Dr. Barry Freedman from Wake Forest University School of Medicine.<img src="http://feeds.feedburner.com/~r/ki/podcast/current/~4/djlTmt1b32I" height="1" width="1"/> http://media.nature.com/download/nature/podcast/ki/ki_01072009.mp3 Wed, 1 July 2009 14:00:00 GMT Science Technology Education Kidney International The MYH9 gene underlying FSGS is strongly associated with hypertension-associated kidney disease in African Americans. 9:57 no Kidney International, Nature, ISN, International Society of Nephrology, nephrology, kidney, urology, hypertension, dialysis, diabetes podcast@nature.comnoThe latest podcast from Kidney International focuses on MYH9 and its role in Focal Segmental Glomerulosclerosis and related disorders. MYH9 is strongly associated with the disease historically labeled "hypertension-associated" ESRD. Recent genetic studiespodcast@nature.comThe latest podcast from Kidney International focuses on MYH9 and its role in Focal Segmental Glomerulosclerosis and related disorders. MYH9 is strongly associated with the disease historically labeled "hypertension-associated" ESRD. Recent genetic studies suggest that the spectrum of FSGS- and global glomerulosclerosis-related kidney diseases are likely present in African Americans reportedly with hypertensive ESRD". The podcast features Dr. Barry Freedman from Wake Forest University School of Medicine.kidney,renal,nephrology,dialysis,hypertension,urology,transplantation,diabetes,clinico,pathological,KI,nature,journals,nature,publishing,group,International,Society,of,Nephrology,ISN,/,<meta,name,description,content,Kidney,Internationahttp://media.nature.com/download/nature/podcast/ki/ki_01072009.mp3http://media.nature.com/download/nature/podcast/ki/ki_01072009.mp3 http://feeds.nature.com/~r/ki/podcast/current/~3/jpf0sDiDJDo/ki_28012009.mp3 Listen in as we discuss ultrasmall supermagnetic iron oxides (USPIOs) as alternatives to gadolinium-based contrast agents (GBCAs) in magnetic resonance imaging. In this podcast, Dr. Edward Neuwelt of Oregon Health & Science University discusses the toxic potential of GCBAs in patients with renal impairment, the benefits of supermagnetic iron compounds, and their safety data in patients.<img src="http://feeds.feedburner.com/~r/ki/podcast/current/~4/jpf0sDiDJDo" height="1" width="1"/> http://www.nature.com/ki/podcast/mp3/ki_28012009.mp3 Wednesday, 28 January 2009 18:00:00 GMT Science Technology Education Kidney International This podcast explores recent research in assessing the safety of commonly used medication. Where safety is concerned, the use of larger registries and cohort studies becomes increasingly important. The studies highlighted in this podcast look at the safety of two commonly used medications often taken by postmenopausal women: oral estrogen therapy and the bisphosphonate zoledronic acid. 8:00 no Kidney International, Nature, ISN, International Society of Nephrology, nephrology, kidney, urology, hypertension, dialysis, diabetes podcast@nature.comnoListen in as we discuss ultrasmall supermagnetic iron oxides (USPIOs) as alternatives to gadolinium-based contrast agents (GBCAs) in magnetic resonance imaging. In this podcast, Dr. Edward Neuwelt of Oregon Health & Science University discusses the toxic podcast@nature.comListen in as we discuss ultrasmall supermagnetic iron oxides (USPIOs) as alternatives to gadolinium-based contrast agents (GBCAs) in magnetic resonance imaging. In this podcast, Dr. Edward Neuwelt of Oregon Health & Science University discusses the toxic potential of GCBAs in patients with renal impairment, the benefits of supermagnetic iron compounds, and their safety data in patients.kidney,renal,nephrology,dialysis,hypertension,urology,transplantation,diabetes,clinico,pathological,KI,nature,journals,nature,publishing,group,International,Society,of,Nephrology,ISN,/,<meta,name,description,content,Kidney,Internationahttp://www.nature.com/ki/podcast/mp3/ki_28012009.mp3http://www.nature.com/ki/podcast/mp3/ki_28012009.mp3 http://feeds.nature.com/~r/ki/podcast/current/~3/Rx1HAsj5rfw/ki_08122008.mp3 This podcast explores recent research in assessing the safety of commonly used medication. Where safety is concerned, the use of larger registries and cohort studies becomes increasingly important. The studies highlighted in this podcast look at the safety of two commonly used medications often taken by postmenopausal women: oral estrogen therapy and the bisphosphonate zoledronic acid.<img src="http://feeds.feedburner.com/~r/ki/podcast/current/~4/Rx1HAsj5rfw" height="1" width="1"/> http://www.nature.com/ki/podcast/mp3/ki_08122008.mp3 Monday, 8 December 2008 18:00:00 GMT Science Technology Education Kidney International This podcast explores recent research in assessing the safety of commonly used medication. Where safety is concerned, the use of larger registries and cohort studies becomes increasingly important. The studies highlighted in this podcast look at the safety of two commonly used medications often taken by postmenopausal women: oral estrogen therapy and the bisphosphonate zoledronic acid. 15:04 no Kidney International, Nature, ISN, International Society of Nephrology, nephrology, kidney, urology, hypertension, dialysis, diabetes podcast@nature.comnoThis podcast explores recent research in assessing the safety of commonly used medication. Where safety is concerned, the use of larger registries and cohort studies becomes increasingly important. The studies highlighted in this podcast look at the safetpodcast@nature.comThis podcast explores recent research in assessing the safety of commonly used medication. Where safety is concerned, the use of larger registries and cohort studies becomes increasingly important. The studies highlighted in this podcast look at the safety of two commonly used medications often taken by postmenopausal women: oral estrogen therapy and the bisphosphonate zoledronic acid.kidney,renal,nephrology,dialysis,hypertension,urology,transplantation,diabetes,clinico,pathological,KI,nature,journals,nature,publishing,group,International,Society,of,Nephrology,ISN,/,<meta,name,description,content,Kidney,Internationahttp://www.nature.com/ki/podcast/mp3/ki_08122008.mp3http://www.nature.com/ki/podcast/mp3/ki_08122008.mp3 http://feeds.nature.com/~r/ki/podcast/current/~3/ylm8NoMpI1Y/ki_03092008.mp3 In our Kidney Podcast, expert commentary is provided by Dr Marcus Ketteler of Universitat Wurzburg and Dr W Charles O’Neill of Emory University. This podcast includes an overview of the process, insight into interpreting the calcium phosphate product, and discussion of promising research options.<img src="http://feeds.feedburner.com/~r/ki/podcast/current/~4/ylm8NoMpI1Y" height="1" width="1"/> http://www.nature.com/ki/podcast/mp3/ki_03092008.mp3 Wed, 3 September 2008 18:00:00 GMT Science Technology Education Kidney International In our Kidney Podcast, expert commentary is provided by Dr. Marcus Ketteler of Universitat Wurzburg and Dr. W. Charles O’Neill of Emory University. This podcast includes an overview of the process, insight into interpreting the calcium phosphate product, and discussion of promising research options. 9:58 no Kidney International, Nature, ISN, International Society of Nephrology, nephrology, kidney, urology, hypertension, dialysis, diabetes podcast@nature.comnoIn our Kidney Podcast, expert commentary is provided by Dr Marcus Ketteler of Universitat Wurzburg and Dr W Charles O’Neill of Emory University. This podcast includes an overview of the process, insight into interpreting the calcium phosphate product, andpodcast@nature.comIn our Kidney Podcast, expert commentary is provided by Dr Marcus Ketteler of Universitat Wurzburg and Dr W Charles O’Neill of Emory University. This podcast includes an overview of the process, insight into interpreting the calcium phosphate product, and discussion of promising research options.kidney,renal,nephrology,dialysis,hypertension,urology,transplantation,diabetes,clinico,pathological,KI,nature,journals,nature,publishing,group,International,Society,of,Nephrology,ISN,/,<meta,name,description,content,Kidney,Internationahttp://www.nature.com/ki/podcast/mp3/ki_03092008.mp3http://www.nature.com/ki/podcast/mp3/ki_03092008.mp3 http://feeds.nature.com/~r/ki/podcast/current/~3/cq8ADkS6SOQ/ki_03062008.mp3 Listen in! In our latest podcast, we discuss acute kidney injury (AKI), which affects approximately 10% of hospitalized patients. In an interview with Dr. Joseph Bonventre of Harvard Medical School and Brigham & Women’s Hospital, we review the utilization of biomarkers to diagnose AKI, the difficulties in introducing new biomarker techniques, and the future of AKI treatment.<img src="http://feeds.feedburner.com/~r/ki/podcast/current/~4/cq8ADkS6SOQ" height="1" width="1"/> http://www.nature.com/ki/podcast/mp3/ki_03062008.mp3 Tue, 3 June 2008 18:00:00 GMT Science Technology Education Kidney International Listen in! In our latest podcast, we discuss acute kidney injury (AKI), which affects approximately 10% of hospitalized patients. In an interview with Dr. Joseph Bonventre of Harvard Medical School and Brigham & Women’s Hospital, we review the utilization of biomarkers to diagnose AKI, the difficulties in introducing new biomarker techniques, and the future of AKI treatment. 10:25 no Kidney International, Nature, ISN, International Society of Nephrology, nephrology, kidney, urology, hypertension, dialysis, diabetes podcast@nature.comnoListen in! In our latest podcast, we discuss acute kidney injury (AKI), which affects approximately 10% of hospitalized patients. In an interview with Dr. Joseph Bonventre of Harvard Medical School and Brigham & Women’s Hospital, we review the utilizationpodcast@nature.comListen in! In our latest podcast, we discuss acute kidney injury (AKI), which affects approximately 10% of hospitalized patients. In an interview with Dr. Joseph Bonventre of Harvard Medical School and Brigham & Women’s Hospital, we review the utilization of biomarkers to diagnose AKI, the difficulties in introducing new biomarker techniques, and the future of AKI treatment.kidney,renal,nephrology,dialysis,hypertension,urology,transplantation,diabetes,clinico,pathological,KI,nature,journals,nature,publishing,group,International,Society,of,Nephrology,ISN,/,<meta,name,description,content,Kidney,Internationahttp://www.nature.com/ki/podcast/mp3/ki_03062008.mp3http://www.nature.com/ki/podcast/mp3/ki_03062008.mp3 http://feeds.nature.com/~r/ki/podcast/current/~3/hxLK2W3LPbE/ki_12_07.mp3 What happens when people go outside their communities to seek organ transplants? Have organs developed into commodities? Listen as we discuss the world of organ trafficking, and implications behind the exchange of money for organs.<img src="http://feeds.feedburner.com/~r/ki/podcast/current/~4/hxLK2W3LPbE" height="1" width="1"/> http://www.nature.com/ki/podcast/mp3/ki_12_07.mp3 Mon, 10 December 2007 18:00:00 GMT Science Technology Education Kidney International What happens when people go outside their communities to seek organ transplants? Have organs developed into commodities? Listen as we discuss the world of organ trafficking, and implications behind the exchange of money for organs. 5:56 no Kidney International, Nature, ISN, International Society of Nephrology, nephrology, kidney, urology, hypertension, dialysis, diabetes podcast@nature.comnoWhat happens when people go outside their communities to seek organ transplants? Have organs developed into commodities? Listen as we discuss the world of organ trafficking, and implications behind the exchange of money for organs.podcast@nature.comWhat happens when people go outside their communities to seek organ transplants? Have organs developed into commodities? Listen as we discuss the world of organ trafficking, and implications behind the exchange of money for organs.kidney,renal,nephrology,dialysis,hypertension,urology,transplantation,diabetes,clinico,pathological,KI,nature,journals,nature,publishing,group,International,Society,of,Nephrology,ISN,/,<meta,name,description,content,Kidney,Internationahttp://www.nature.com/ki/podcast/mp3/ki_12_07.mp3http://www.nature.com/ki/podcast/mp3/ki_12_07.mp3 http://feeds.nature.com/~r/ki/podcast/current/~3/6M-VA9HVZGk/ki_11_06_07.mp3 In this show, we take a trip to the International Congress of Nephrology in Rio de Janeiro to investigate the grip your kidneys have over your heart, and sample the hottest research fresh from the pages of Kidney International<img src="http://feeds.feedburner.com/~r/ki/podcast/current/~4/6M-VA9HVZGk" height="1" width="1"/> http://www.nature.com/ki/podcast/mp3/ki_11_06_07.mp3 Mon, 18 June 2007 18:00:00 GMT Science Technology Education Kidney International In this show, we take a trip to the International Congress of Nephrology in Rio de Janeiro to investigate the grip your kidneys have over your heart, and sample the hottest research fresh from the pages of Kidney International 24:04 no Kidney International, Nature, ISN, International Society of Nephrology, nephrology, kidney, urology, hypertension, dialysis, diabetes podcast@nature.comnoIn this show, we take a trip to the International Congress of Nephrology in Rio de Janeiro to investigate the grip your kidneys have over your heart, and sample the hottest research fresh from the pages of Kidney Internationalpodcast@nature.comIn this show, we take a trip to the International Congress of Nephrology in Rio de Janeiro to investigate the grip your kidneys have over your heart, and sample the hottest research fresh from the pages of Kidney Internationalkidney,renal,nephrology,dialysis,hypertension,urology,transplantation,diabetes,clinico,pathological,KI,nature,journals,nature,publishing,group,International,Society,of,Nephrology,ISN,/,<meta,name,description,content,Kidney,Internationahttp://www.nature.com/ki/podcast/mp3/ki_11_06_07.mp3http://www.nature.com/ki/podcast/mp3/ki_11_06_07.mp3 nonadultKidney International - Podcasts